Legislation & Regulation
Richard Mark Kirkner


The public wants it. Presidential candidates are talking about it. Will Congress make it happen?
Medication Management
Thomas Reinke
Two companies, two drugs for Duchenne muscular dystrophy in the expedited approval process. The stakes are high, especially for patients and their families.
Tomorrow’s Medicine
Thomas Morrow, MD
This newest asthma medication—two decades in development—offers millions new hope. Good stuff, say many, but costly.
Andrew J. Haig, MD
As costs for treating back pain skyrocket, some stakeholders turn to a team approach featuring this little-used specialist.
News & Commentary
Frank Diamond

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report